Phase
Condition
Cancer Treatment
Treatment
N/AClinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
with malignant tumors
will receive radiotherapy
with cardiac exposure during the radiotherapy process
could receive regular follow-up for 12 months
written informed consent
Exclusion
Exclusion Criteria:
satisfactory echocardiographic images could not be obtained
moderate or severe valvular disease
cardiomyopathy
congenital heart disease
refractory hypertension
coronary artery disease*
heart failure
arrhythmia requiring intervention
pericarditis
acute myocarditis
participating in other clinical studies of drug intervention
severe liver and kidney dysfunction
autoimmune disease
pulmonary hypertension coronary artery disease: at least 50% stenosis besed on previous coronary angiography orCTA, or with a history of percutaneous coronary stent implantation.
*: with LVEF<50%, unstable angina,or acute myocardial infarction within 3 months.
Study Design
Study Description
Connect with a study center
Peking University Third Hospital
Beijing, Beijing 100191
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.